Columbia researchers found that a gene associated with an autoimmune form of hair loss could be activated to improve cancer immunotherapy.
Researchers discovered a mechanism that reprograms tumor cells in patients with advanced prostate cancer, reducing their response to anti-androgen therapy.
Columbia University scientists study tumor revertants as possible new approach to cancer therapy.
Based on new evidence, laparoscopic surgery should be offered to most women with early-stage endometrial cancer, says Columbia’s gynecologic cancer chief.
A public-private research effort aims to develop more accurate ways of tracking a patient’s response to cancer therapy.
The drug, developed by Columbia and MSK researchers, selectively kills cancer cells and has shown activity against multiple malignancies in pre-clinical studies.